Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.

MLA

Dermaut, B., et al. “Cerebral Amyloid Angiopathy Is a Pathogenic Lesion in Alzheimer’s Disease Due to a Novel Presenilin 1 Mutation.” Brain: A Journal of Neurology, vol. 124, no. 12, Dec. 2001, pp. 2383–92. EBSCOhost, https://doi.org/10.1093/brain/124.12.2383.

APA

Dermaut, B., Kumar-Singh, S., De Jonghe, C., Cruts, M., Löfgren, A., Lübke, U., Cras, P., Dom, R., De Deyn, P. P., Martin, J. J., & Van Broeckhoven, C. (2001). Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer’s disease due to a novel presenilin 1 mutation. Brain: A Journal of Neurology, 124(12), 2383–2392. https://doi.org/10.1093/brain/124.12.2383

Chicago

Dermaut, B, S Kumar-Singh, C De Jonghe, M Cruts, A Löfgren, U Lübke, P Cras, et al. 2001. “Cerebral Amyloid Angiopathy Is a Pathogenic Lesion in Alzheimer’s Disease Due to a Novel Presenilin 1 Mutation.” Brain: A Journal of Neurology 124 (12): 2383–92. doi:10.1093/brain/124.12.2383.